The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ERIC 2020 | Future genetic testing with a single combined gene panel for CLL
Richard Rosenquist, MD, PhD, Karolinska University Hospital, Solna, Sweden, discusses the future of genetic testing. Prof. Rosenquist expresses interest in a single combined gene panel that would encompass chromosomal mutations, IgHV mutation status and TP53 mutations. This could be possible within the next few years with the use of capture-based gene panels. This interview took place during the European Research Initiative on CLL (ERIC) International Virtual Meeting 2020.
